期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

替米沙坦联合氨氯地平治疗射血分数正常的心力衰竭疗效观察 被引量：4

下载PDF
导出
摘要 目的观察替米沙坦联合氨氯地平治疗射血分数正常的心力衰竭(HFNEF)的疗效。方法将57例HFNEF患者随机分为治疗组30例和对照组27例,治疗组给予替米沙坦联合氨氯地平口服,对照组仅给予氨氯地平口服,均用药8周。结果与对照组相比,治疗组患者左室射血分数、左室舒张末期容积指数升高,左室舒张早期二尖瓣脉冲多普勒血流速度与组织多普勒二尖瓣环运动速度的比值降低,血浆脑钠肽水平显著降低(P均<0.05)。结论替米沙坦与氨氯地平联用治疗HFNEF疗效优于单用氨氯地平。
作者 陈彩萍 徐承
机构地区 苏州大学附属第四医院
出处 《山东医药》 CAS 北大核心 2011年第35期80-81,共2页 Shandong Medical Journal
关键词 心力衰竭 替米沙坦 氨氯地平
分类号 R541.6 [医药卫生—心血管疾病]
  • 相关文献

参考文献6

  • 1Sharon AH,William TA,Marshall HC,et al.ACC/AHA 2005guideline update for the diagnosis and management of chronic heart failure in the adult[J].Circulation,2005,112(12):1825-1852.
  • 2Paulus W J,Tschope C,Sanderson JE,et al.How to diagnose diastolic heart failure:a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Hear Failure and Echocardiography Associations of the European Society of Cardiology[J].Eur Heart J,2007,28(20):2539-2550.
  • 3Zile MR,Brutsaert DL.New concepts indiastolic dysfunction and diastolic hert failure:part 1 causal mechanisms and treatment[J].Circulation,2002,105 (12):1503-1508.
  • 4Kass DA,Bronzwaer JG,Paulus WJ.What mechanisms underlie diastolic dysfunction in heart failure[J].Circ Res,2004,94(12):1533-1542.
  • 5Yip GW,Wang M,Wang T,et al.The Hong Kong diastolic heart failure study:a randomised controlled trial of diuretics,irbesartan and ramipril on quality of life,exercise capacity,left ventricular global and regional function in heart failure with a normal ejection fraction[J].Heart,2008,94(5):573-580.
  • 6刘启明,崔永亮,陈丽华,周胜华.射血分数正常的心力衰竭的研究进展[J].国际心血管病杂志,2009,36(3):148-150. 被引量：5

二级参考文献18

  • 1Ahmed A,Roseman JM,Duxbury AS,et al.Correlates and outcomes of preserved left ventricular systolic function among older adults hospitalized with heart failure[J].Am Heart J,2002,144(2):365-372.
  • 2Hogg K,Swedberg K,McMurray J.Heart failure with preserved left ventricular systolic function:epidcmiology,clinical characteristics,and prognosis[J].J Am Coll Cardiol,2004,43(3):317-327.
  • 3Paulus WJ,Tschope C,Sanderson JE,et al.How to diagnose diastolic heart failure:a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology[J].Eur Heart J,2007,28(20):2539-2550.
  • 4Brucks S,Little WC,Chao T,et al.Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction[J,].Am J Cardiol,2005,95(5):603-606.
  • 5Zile MR,Brutsaert DL.New Concepts in Diastolic Dysfunction and Diastolic Heart Failure:Part Ⅱ Causal Mechanisms and Treatment[J].Circulation,2002,105(12):1503-1508.
  • 6Kass DA,Bronzwaer JG,Paulus WJ.What mechanisms underlie diastolic dysfunction in heart failure?[J].Circ Res,2004,94(12):1533-1542.
  • 7Oh JK,Hatle L,Tajik AJ,Little WC.Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echoeardiography[J].J Am Coll Cardiol,2006,47(3):500-506.
  • 8Little WC.Heart failure with a normal left ventrieular ejection fraction:diastolic heart failure[J].Trans Am Clin Climatol Assoc,2008,119:93-99 ;discussion 99-102.
  • 9Schmidt AG,Pieske B.Diastolic heart failure-diagnostics[J].Dtsch Med Woehenschr,2005,130(19):1208-1212;quiz 1217-1220.
  • 10Yip GW,Wang M,Wang T,et al.The Hong Kong diastolic heart failure study:a randomised controlled trial of diuretics,irbesartan and ramipril on quality of life,exercise capacity,left ventricular global and regional function in heart failure with a normal cjection fraction[J].Heart,2008,94(5):573-580.

同被引文献50

  • 1周春丽.替米沙坦联合氨氯地平治疗心力衰竭的疗效[J].中国药物经济学,2013,8(S2):242-243. 被引量：1
  • 2秦海斌.琥珀酸美托洛尔等药品对左室射血分数正常心力衰竭患者的影响[J].现代养生,2014,0(14):83-83. 被引量：4
  • 3赵林双,向光大,周子华,孙慧伶,乐岭,戚本玲.缬沙坦治疗高血压病合并舒张性心功能不全116例[J].中国新药与临床杂志,2006,25(10):762-765. 被引量：8
  • 4Go AS,Mozaffarian D,Roger VL,et al.Heart disease and stroke statistics--2014 update:a report from the American Heart Association.Circulation,2014,129(3):e28-e292.
  • 5Roger VL,Weston SA,Redfield MM,et al.Trends in heart failure incidence and survival in a community-based population.JAMA,2004,292(3):344-350.
  • 6Levy D,Kenchaiah S,Larson MG,et al.Long-term trends in the incidence of and survival with heart failure.N Engl J Med,2002,347(18):1397-1402.
  • 7Suter LG,Li SX,Grady JN,et al.National patterns of risk-standardized mortality and readmission after hospitalization for acute myocardial infarction,heart failure,and pneumonia:update on publicly reported outcomes measures based on the 2013 release.J Gen Intern Med,2014,29(10):1333-1340.
  • 8Tribouilloy C,Rusinaru D,Mahjoub H,et al.Prognosis of heart failure with preserved ejection fraction:a 5 year prospective population-based study.Eur Heart J,2008,29(3):339-347.
  • 9Owan TE,Hodge DO,Herges RM,et al.Trends in prevalence and outcome of heart failure with preserved ejection fraction.N Engl J Med,2006,355(3):251-259.
  • 10Fonarow GC,Stough WG,Abraham WT,et al.Characteristics,treatments,and outcomes of patients with preserved systolic function hospitalized for heart failure:a report from the OPTIMIZE-HF Registry.J Am Coll Cardiol,2007,50(8):768-777.

引证文献4

二级引证文献16

山东医药
2011年 第35期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部